Felbatol: Warning Removed

Felbatol is a very powerful antiepileptic medicine used to treat a broad variety of seizure and seizure syndrome types. Historically, it has been a difficult medicine for physicians to prescribe because it interacts with a great many other medicines, including other antiepileptic medications. Determining proper dosing can also be difficult. Shortly after Felbatol was introduced to market, a few of those who use it developed severe blood dyscrasias and died unexpectedly. The Food and Drug Administration (FDA) issued a warning and required that the medication be used only for very difficult-to-control patients. They suggested further testing. 

As more data has been gathered, the FDA has withdrawn the warning and Felbatol is now approved for more ordinary use. The problem was not as serious as first thought. If patients have not had severe reactions to other drugs, they are not likely to have a severe reaction to Felbatol. 

Nonetheless, it is a difficult drug to use well. Patients whose seizures have not responded to other medicines might well react favorably to Felbatol, but it is recommended that they be in the hands of a physician who is familiar with the medicine.

This site is presented for information only and is not intended to substitute for professional medical advice. Use of this site is subject to a disclaimer. Presentation and design ©Copyright 2000 Rev. 2005 MINCEP® Epilepsy Care.
All Rights Reserved.